Cargando…

Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer

Human papillomavirus (HPV) status strongly predicts positive clinical outcomes in patients with head and neck squamous cell cancer (HNSCC); however, the potential reasons have not been fully elucidated. Here, we characterized the immune context in HPV+ and HPV− HNSCC by integrating scRNA-seq and bul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhongqiu, Wang, Qingxin, Tao, Yuxuan, Chen, Jingru, Yuan, Zhiyong, Wang, Peiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570276/ https://www.ncbi.nlm.nih.gov/pubmed/37828063 http://dx.doi.org/10.1038/s41597-023-02611-3

Ejemplares similares

Pyroptosis patterns influence the clinical outcome and immune microenvironment characterization in HPV-positive head and neck squamous cell carcinoma
por: Li, Doudou, et al.
Publicado: (2023)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
por: Benavente, Sergi
Publicado: (2023)

Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
por: Lim, Yenkai, et al.
Publicado: (2016)

Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers
por: Dok, Rüveyda, et al.
Publicado: (2021)

Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
por: Wegge, Marilyn, et al.
Publicado: (2021)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
por: Lechien, Jérôme R., et al.
Publicado: (2020)

DEK promotes HPV positive and negative head and neck cancer cell proliferation
por: Adams, Allie K., et al.
Publicado: (2014)

Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients
por: Wan, Yunxia, et al.
Publicado: (2017)

HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2019)

Deciphering the Tumor–Immune–Microbe Interactions in HPV-Negative Head and Neck Cancer
por: Hu, Min, et al.
Publicado: (2023)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
por: Stögbauer, Fabian, et al.
Publicado: (2023)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
por: Reid, Paul, et al.
Publicado: (2020)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges
por: Chantre-Justino, Mariana, et al.
Publicado: (2022)

A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing
por: Nichols, Anthony C., et al.
Publicado: (2012)

FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022)

Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Chen, Yifei, et al.
Publicado: (2021)

Immune Cells in Head-and-Neck Tumor Microenvironments
por: Jumaniyazova, Enar, et al.
Publicado: (2022)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
por: Ferris, Robert L, et al.
Publicado: (2021)

mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
por: Coppock, Joseph D., et al.
Publicado: (2016)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma
por: O’Neill, W. Quinn, et al.
Publicado: (2022)

The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer
por: Conarty, Jacob P., et al.
Publicado: (2023)

Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Publicado: (2021)

Proteomic Study of HPV-Positive Head and Neck Cancers: Preliminary Results
por: Descamps, Géraldine, et al.
Publicado: (2014)

Special Issue about Head and Neck Cancers: HPV Positive Cancers
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
por: Deneka, Alexander Y., et al.
Publicado: (2020)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Targeting DNA Double-Strand Break Repair Enhances Radiosensitivity of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma to Photons and Protons
por: Vitti, Eirini Terpsi, et al.
Publicado: (2020)

Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer
por: Ge, Hua, et al.
Publicado: (2020)

HPV Associated Head and Neck Cancer
por: Spence, Tara, et al.
Publicado: (2016)

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Multiplex immunohistochemistry for immune profiling of HPV-associated head and neck cancer
por: Tsujikawa, Takahiro, et al.
Publicado: (2015)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
por: Jin, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e5uqqipia2s2on3u79qp71cebm